Chemours Company Target Price

Analysts' average 12-month price target for Chemours Company is $18.

Get informed when a big investor buys or sells

+ Follow

Share Price

$12.81

Average Target Price

$17.91

39.8% upside

11 analysts in the last 4 months

High: $22 | Low: $14

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-10-20	Truist Financial	$20	56.1% upside
2026-10-13	RBC CapitalArun Viswanathan	$14	9.3% upside
2026-10-12	Barclays	$16	24.9% upside
2026-10-09	Goldman SachsDuffy Fischer	$16	24.9% upside
2026-10-05	UBS	$16	24.9% upside
2026-08-13	Goldman SachsDuffy Fischer	$17	32.7% upside
2026-08-13	BMO Capital	$18	40.5% upside
2026-08-10	Morgan StanleyVincent Andrews	$18	40.5% upside
2026-08-10	UBSJoshua Spector	$18	40.5% upside
2026-08-06	RBC Capital	$22	71.7% upside
2026-08-05	Mizuho Securities	$22	71.7% upside
2026-05-13	Alembic Global	$30	134.2% upside
2026-05-11	Morgan StanleyVincent Andrews	$21	63.9% upside
2026-05-11	RBC Capital	$29	126.4% upside
2026-05-08	UBS	$30	134.2% upside
2026-05-06	Mizuho SecuritiesJohn Roberts	$30	134.2% upside
2026-04-28	Truist FinancialPeter Osterland	$30	134.2% upside
2026-04-10	RBC CapitalArun Viswanathan	$26	103% upside
2026-04-09	Truist Financial	$27	110.8% upside
2026-04-09	UBS	$29	126.4% upside
2026-02-23	UBS	$23	79.5% upside
2026-02-23	Mizuho Securities	$17	32.7% upside
2026-02-23	JefferiesLaurence Alexander	$17	32.7% upside
2026-02-23	Morgan StanleyVincent Andrews	$17	32.7% upside
2026-02-23	BMO Capital	$19	48.3% upside
2026-01-21	Truist Financial	$21	63.9% upside
2026-01-19	BMO CapitalJohn McNulty	$20	56.1% upside
2026-01-16	RBC Capital	$18	40.5% upside
2025-11-10	Truist FinancialPeter Osterland	$18	40.5% upside
2025-10-16	Mizuho SecuritiesJohn Roberts	$18	40.5% upside
2025-10-14	RBC Capital	$19	48.3% upside
2025-10-06	UBSJoshua Spector	$21	63.9% upside
2025-09-23	Mizuho SecuritiesJohn Roberts	$19	48.3% upside
2025-05-07	UBSJoshua Spector	$17	32.7% upside
2025-04-15	Mizuho SecuritiesJohn Roberts	$15	17.1% upside
2024-10-11	RBC CapitalArun Viswanathan	$28	118.6% upside
2024-10-07	BMO CapitalJohn McNulty	$32	149.8% upside
2024-08-06	BMO CapitalJohn McNulty	$30	134.2% upside
2024-06-07	Mizuho SecuritiesJohn Roberts	$25	95.2% upside
2024-05-29	UBSRich Hilliker	$31	142% upside
2024-04-09	BMO CapitalJohn McNulty	$34	165.4% upside
2024-04-01	UBSJoshua Spector	$28	118.6% upside
2024-04-01	CFRAEmily Nassedd Mitsch	$18	40.5% upside
2024-03-13	D.A. DavidsonLinda Bolton Weiser	$24	87.4% upside
2023-12-01	RBC CapitalArun Viswanathan	$40	212.3% upside
2023-10-30	Morgan StanleyVincent Andrews	$33	157.6% upside
2023-01-10	RBC CapitalArun Viswanathan	$33	157.6% upside
2022-05-04	RBC Capital	$48	274.7% upside
2021-05-20	Bank of America SecuritiesMatthew DeYoe	$42	227.9% upside
2021-05-10	Morgan StanleyVincent Andrews	$35	173.2% upside

Chemours Company (CC) FAQ

The latest target price for CC is $18. Investors often review this figure alongside Chemours Company's historical trend and sector peers before judging valuation or financial health.

Chemours Company trades near $12.81 while the consensus target sits at $18 (39.8% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting CC's target price ($18), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Chemours Company's target price against similar Consumer Discretionary names. You can also browse sector and industry screens on Stockcircle for a broader set of Consumer Discretionary companies and their key multiples and fundamentals.